NEW YORK (GenomeWeb) – Genome Canada announced today that it has partnered with various Canadian provinces and organizations to invest a total of C$255 million ($204.4 million) in two initiatives advancing precision medicine and genomic technology development.

Under the first initiative, Genome Canada, the Canadian Institutes of Health Research, and other partners will provide C$162 million over four years to support 15 precision medicine and genomics projects underway across Canada.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
05

This webinar will discuss how Sanofi used literature mining to annotate the association of human leukocyte antigen (HLA) alleles with diseases and drug hypersensitivity as part of a multiple sclerosis (MS) biomarker discovery project.

Jun
14

This webinar will discuss an effort underway at the University of North Carolina Medical Center's to overcome limitations in the hematological genomic testing workflow with artificial intelligence (AI) from Sophia Genetics.